Crystal structure-based selective targeting of the pyridoxal 5?-phosphate dependent enzyme kynurenine aminotransferase II for cognitive enhancement

Franca Rossi, Casazza Valentina, Silvia Garavaglia, Korrapati V. Sathyasaikumar, Robert Schwarcz, Shin Ichi Kojima, Keisuke Okuwaki, Shin Ichiro Ono, Yasushi Kajii, Menico Rizzi

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Fluctuations in the brain levels of the neuromodulator kynurenic acid may control cognitive processes and play a causative role in several catastrophic brain diseases. Elimination of the pyridoxal 5?-phosphate dependent enzyme kynurenine aminotransferase II reduces cerebral kynurenic acid synthesis and has procognitive effects. The present description of the crystal structure of human kynurenine aminotransferase II in complex with its potent and specific primary amine-bearing fluoroquinolone inhibitor (S)-(?)-9-(4-aminopiperazin-1-yl)-8- fluoro-3-methyl-6-oxo-2,3-dihydro-6H-1-oxa-3a-azaphenalene-5-carboxylic acid (BFF-122) should facilitate the structure-based development of cognition-enhancing drugs. From a medicinal chemistry perspective our results demonstrate that the issue of inhibitor specificity for highly conserved PLP-dependent enzymes could be successfully addressed.

Lingua originaleInglese
pagine (da-a)5684-5689
Numero di pagine6
RivistaJournal of Medicinal Chemistry
Volume53
Numero di pubblicazione15
DOI
Stato di pubblicazionePubblicato - 12 ago 2010

Fingerprint

Entra nei temi di ricerca di 'Crystal structure-based selective targeting of the pyridoxal 5?-phosphate dependent enzyme kynurenine aminotransferase II for cognitive enhancement'. Insieme formano una fingerprint unica.

Cita questo